SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
392.00    2.00 (0.51%)
Bid:
385.00
Ask:
399.00
Spread: 14.00 (3.636%)
Market Cap: £188.15m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Trading Update

28 Apr 2011 14:08

RNS Number : 6666F
Tristel PLC
28 April 2011
Β 

ο»Ώ

Β 

28th April 2011

Tristel plc

("Tristel" or "the Company")

AIM: TSTL

Β 

Trading Update

License Delays and Trading Update

Tristel plc, the manufacturer of infection control, contamination control and hygiene products, announces that as a consequence of delays in receipt of the licence to sell its Stella tray system in China and the delay in securing inclusion of its Wipes System on Germany's VAH listing, a substantial portion of revenues originally anticipated to fall in its current financial year will now be deferred to the financial year commencing 1 July 2011. The Company's planned expansion into the Pharmaceutical and Personal Care market with its "Crystel" range of disinfectants and cleaning products has also had a slower start than anticipated.

Whilst the Company is confident that the license delays referred to above will be successfully concluded, it is unlikely that Germany and China will make the positive contribution to the current year's result originally anticipated. Therefore, the Company now anticipates results for the second half will be at least break-even (pre-IFRS 2 charge) delivering a full year pre-tax profit of no less than Β£433,000.

In line with its expansion plan, the Company has continued to invest in sales and manufacturing infrastructure and the second half result is, therefore, bearing a much enlarged cost base. The Company remains debt free and will continue with its expansion plan as detailed in the interim results. Significant growth is anticipated in 2012 and beyond.

For further information, please contact:

Tristel plc

Β 

Paul Swinney, Chief Executive

Tel: 01638 721 500

Β 

Β 

finnCap

Β 

Geoff Nash / Charlotte Stranner (Corporate Finance)

Tel: 020 7600 1658

Β 

Β 

Walbrook PR

Tel: 020 7933 8780

Paul McManus (Media Enquiries)

Mob: 07917 575 484

Β 

paul.mcmanus@walbrookpr.com

Paul Cornelius (Investor Enquiries)

DD: 020 7933 8794

Β 

paul.cornelius@walbrookir.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTXVLFLFZFBBBD
Date   Source Headline
23rd Feb 20224:45 pmRNSInterim dividend confirmation
22nd Feb 202211:30 amRNSDirector/PDMR Shareholding
21st Feb 20224:40 pmRNSSecond Price Monitoring Extn
21st Feb 20224:35 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSHalf-year Report
17th Feb 20223:00 pmRNSIssue of Equity
1st Feb 20227:00 amRNSConfirmation of Interim Results
13th Dec 20215:13 pmRNSResult of AGM
13th Dec 20217:00 amRNSAGM Statement and notice of results
27th Oct 20217:00 amRNSDirector/PDMR Shareholding
21st Oct 20214:39 pmRNSDirector/PDMR Shareholding
19th Oct 20215:35 pmRNSHolding(s) in Company
18th Oct 20213:50 pmRNSIssue of Equity
18th Oct 202111:59 amRNSDirector/PDMR Shareholding
18th Oct 20217:00 amRNSFinal Results
12th Oct 20215:58 pmRNSHolding(s) in Company
22nd Sep 20217:00 amRNSNotice of Results
23rd Aug 20217:00 amRNSIssue of Equity
10th Aug 20217:00 amRNSIssue of Equity
29th Jul 20216:29 pmRNSTR1: Notification of Major Holdings
21st Jul 20217:00 amRNSTrading update
9th Jul 20211:21 pmRNSIssue of Equity
24th Jun 20217:00 amRNSRegulatory approval for EPA, Canada & South Korea
8th Jun 20217:00 amRNSIssue of Equity
13th May 20213:30 pmRNSIssue of Equity
26th Apr 20213:15 pmRNSDirector/PDMR Shareholding
26th Apr 20212:06 pmRNSSecond Price Monitoring Extn
26th Apr 20212:00 pmRNSPrice Monitoring Extension
26th Apr 202111:05 amRNSSecond Price Monitoring Extn
26th Apr 202111:00 amRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSTrading Update
21st Apr 20213:00 pmRNSIssue of Equity
19th Apr 20211:00 pmRNSIssue of Equity
6th Apr 20211:00 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights
26th Mar 202110:40 amRNSIssue of Equity
4th Mar 20217:00 amRNSDirector/PDMR Shareholding
1st Mar 20215:00 pmRNSDirector/PDMR Shareholding and Issue of Equity
22nd Feb 20217:00 amRNSHalf-year Report
18th Feb 202111:15 amRNSNotice of investor presentation
15th Feb 202111:00 amRNSIssue of Equity
29th Jan 20217:00 amRNSIssue of Equity
14th Jan 20212:00 pmRNSExercise of Options
24th Dec 20207:00 amRNSDirector Appointment
15th Dec 202011:39 amRNSResult of AGM
15th Dec 20207:00 amRNSAGM Statement and notice of results
2nd Dec 20202:00 pmRNSUpdate to Executive Performance Share Plan 2021
2nd Dec 202010:30 amRNSTristel wins AIM Growth Business of the Year Award
9th Nov 20209:49 amRNSExercise of Options
2nd Nov 202010:30 amRNSQ&A update following preliminary results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.